Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Travere Therapeutics' Chief Legal Officer, Elizabeth E. Reed, sold 46,600 shares of common stock on April 14 and 15, 2026, realizing roughly $2.13 million. The transactions followed option exercises and the vesting of performance restricted stock units tied to FDA approval of the company's drug Filspari. The equity trades occurred as the shares tra…
Travere Therapeutics Chief Financial Officer Christopher R. Cline reported a series of stock transactions between April 13 and April 15, 2026, that resulted in $348,974 of sales. The filings show discrete sales at prices ranging from $28.85 to $42.61, and the same filings show a separate award of 14,000 common shares at $0 following the vesting of …
Travere Therapeutics CEO Eric M. Dube sold 63,900 shares of common stock on April 15, 2026, in transactions totaling about $2.63 million. The disposals, carried out under a 10b5-1 plan adopted June 16, 2025, coincided with the stock trading near its 52-week high after a 181% gain over the past year. The sales covered tax obligations tied to newly v…
Travere Therapeutics Inc (NASDAQ:TVTX) Chief Commercial Officer Heerma Peter reported a sale of 7,215 shares on April 14, 2026, generating $302,516. The disposition followed a vesting of 14,000 performance-restricted stock units tied to FDA approval of Filspari, with the executive now holding 138,608 shares. The company’s stock is trading near a 52…
Travere Therapeutics Chief Medical Officer Jula Inrig sold 8,233 shares of common stock across April 14 and April 15, 2026, realizing roughly $345,893. The transactions followed the vesting of performance restricted stock units that delivered 14,000 shares on April 13. The insider sales, some executed to meet tax liabilities and including a pre-arr…
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 20,406 shares on April 13 and April 15, 2026, for roughly $548,672 under a pre-arranged Rule 10b5-1 plan. Rodman also exercised options for 14,058 shares on April 13 and now holds 69,792 shares directly. The company reported fourth-quarter 2025 earnings with an EPS of -0.4, beati…
Mineralys Therapeutics Chief Executive Officer Jon Congleton sold 15,730 shares on April 13, 2026, generating roughly $421,979 at weighted-average prices between $26.81 and $26.96. The transaction was carried out under a Rule 10b5-1 plan adopted December 30, 2025. Congleton still holds 689,321 shares. The company reported Q4 2025 EPS of -0.4 versus…
Arxis Inc. set its initial public offering price at $28 per share, selling 40.5 million Class A shares to raise about $1.13 billion. The company expanded the offering size and gave underwriters a 30-day option for up to 6.075 million additional shares. Shares are expected to begin trading on the Nasdaq Global Select Market as ARXS on April 16, with…
Arxis, a maker of electronic and mechanical components for aerospace, defense, medical and specialized industrial markets, raised $1.13 billion in its U.S. initial public offering by selling 40.5 million shares priced at $28 each. The company, owned by buyout firm Arcline, has grown through more than 30 acquisitions since 2019, including the $1.8 b…
A U.S. district judge in Honolulu dismissed the Justice Department's effort to stop Hawaii from pursuing climate-related litigation against major oil companies in state court, finding the federal government's challenge too speculative and noting a longstanding policy against federal intervention in state court processes. The ruling is the second fe…
The U.S. dollar remained close to its lowest levels since early March as growing optimism from the White House about a possible peace deal with Iran encouraged market participants to unwind safe-haven positions. Currency benchmarks and risk-sensitive currencies strengthened, while officials signalled further diplomatic engagement and potential mari…
OpenAI co-founder and CEO Sam Altman filed a motion in federal court in St. Louis seeking to dismiss punitive damages claims in a civil suit brought by his sister, Annie Altman, who accuses him of sexual abuse and rape between 1997 and 2006. In the filing, Sam Altman contends Missouri’s child sexual abuse statute restricts recovery to damages for i…
Electronic Arts Chief People Officer Vijayanthimala Singh, through the Singh-Force Family Trust, sold 1,200 shares on April 15, 2026 at $203.25 each, totaling $243,900. The transaction occurred while EA shares traded close to a 52-week high and amid advancing merger steps and upbeat fiscal third-quarter results. The trust retains 28,760 shares foll…
Electronic Arts CEO Andrew Wilson sold 5,000 shares on April 15, 2026 under a previously arranged 10b5-1 plan, generating $1016058 in proceeds. The trade occurred while EA shares were trading close to a 52-week peak, amid strong quarterly results and progress on a proposed buyout by an investor consortium.
Ouster Chief Technology Officer Mark Frichtl sold 60,000 shares of common stock across April 14 and 15, 2026, for about $1.39 million, according to a Form 4 filing. The transactions were carried out under a pre-arranged Rule 10b5-1 plan and coincided with robust stock performance and solid fourth-quarter results reported by the company.
Laura Miele, President of EA Entertainment at Electronic Arts Inc. (NASDAQ: EA), sold 2,500 shares on April 15, 2026, for $508,025 under a previously established 10b5-1 plan. The transaction occurred as EA shares hovered close to their 52-week high, and follows strong fiscal third-quarter results and progress on a proposed merger with an investor c…
U.S. equity futures ticked higher Wednesday evening after the S&P 500 and Nasdaq Composite closed at record levels, supported by optimism about potential U.S.-Iran talks and continued corporate earnings strength. S&P 500 futures rose 0.2%, Nasdaq 100 futures gained 0.3% and Dow futures edged up 0.2% as investors weighed diplomatic developments and …
A significant fire on Wednesday night at the Geelong refinery in Corio, Victoria - one of Australia’s last two operating refineries - damaged the motor gasoline production unit and forced the plant to run at minimum rates. The facility, owned by Viva Energy Group Ltd (ASX: VEA), supplies roughly half of Victoria’s fuel and about 10% of national con…
Oil prices eased in early trade as signs of potential de-escalation between the United States and Iran — including a report that Iran could permit ships to transit via the Omani side of the Strait of Hormuz if a deal is struck — offset persistent worries over supply disruptions and lower-than-expected inventories in the United States.
On April 16, missile strikes struck Ukraine's capital Kyiv in the early hours, injuring several people, igniting fires and causing damage across multiple districts. City officials reported a missile entered an apartment tower, a major fire erupted in the Obolon district injuring emergency medical personnel, and debris fell in several areas. Regiona…
The U.S. Senate on April 15 defeated two resolutions aimed at stopping roughly $447 million in military equipment transfers to Israel, with Republican senators uniting behind President Donald Trump’s support for the ally. While the Democratic caucus largely supported the measures, the votes fell short in the chamber, underscoring persistent biparti…
Annabelle G. Bexiga, a member of StoneX Group Inc.'s board, sold 1,500 shares of the company's common stock on April 15, 2026, for $152,865. The transaction occurred as the stock traded close to its 52-week high. The company has also announced several strategic moves to bolster cross-border payments, launched a securitization and capital markets pl…
Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares on April 15, 2026, generating roughly $626,199 in proceeds. The sale was executed at prices between $20.76 and $21.07 per share. Maroney retains direct ownership of 1,028,813 shares. The transaction comes while the stock sits about 80% above its 52-week low and is noted by Inv…
Asian markets opened higher amid signs that Iran may be considering proposals to reduce maritime threats in the Strait of Hormuz and as robust corporate results in the United States lifted risk appetite. Market participants are also braced for key economic releases, including Australian employment figures and Chinese GDP, while Taiwan Semiconductor…
Credit ratings agency S&P Global Ratings reduced the issuer credit rating for the Australian Securities Exchange to "A+/A-1" from "AA-/A-1+" following regulatory findings that the exchange exhibited governance and risk management failures. The downgrade arrives after a lengthy ASIC inquiry that highlighted tactical, short-term responses to tech…
